ArticleArchives of medical science : AMS2026
Long-term prognosis in patients suffering from myocardial infarction with non-obstructive coronary arteries, ST-segment elevation myocardial infarction, infective myocarditis and tako-tsubo cardiomyopathy - all-cause mortality comparison.
Article in Archives of medical science : AMS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Myocardial infarction with non-obstructive coronary arteries (MINOCA), tako-tsubo cardiomyopathy (TTC), infective myocarditis (IM) and acute ST-segment elevation myocardial infarction (STEMI) of anterior wall being a heterogeneous group, may occur in very similar clinical presentations. In this study, it was aimed to compare the prognosis and identify predictors of major adverse cardiac and cerebrovascular events (MACCE) and all-cause mortality in these groups of patients. Material and methods: At 2 Polish Academic Cardiology Centres among 596 patients, we compared clinical characteristics and outcomes in 4 groups: MINOCA (318, 53.3%), TTC (31, 5.2%), IM (22, 3.7%) and STEMI (225, 37.7%). MACCE were defined as myocardial infarction (MI), revascularisation (either percutaneous or surgical), all-cause death and stroke/transient ischemic attacks. Survival curves were presented using Kaplan-Meier estimator and compared using log-rank test. Results: Kaplan-Meier survival analysis demonstrated that in the 3-year follow-up period, patients with anterior wall STEMI were at the highest risk of MACCE ( Conclusions: During the 3 years of follow-up, anterior wall STEMI had significantly poorer prognosis in terms of MACCE when compared to the TTC, IM and MINOCA groups. TTC was related to the greatest all-cause mortality, however, without statistical significance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.